{"id":121046,"date":"2020-11-26T20:23:15","date_gmt":"2020-11-26T17:23:15","guid":{"rendered":"https:\/\/en.buradabiliyorum.com\/additional-study-needed-for-astrazeneca-vaccine-company\/"},"modified":"2020-11-26T20:23:15","modified_gmt":"2020-11-26T17:23:15","slug":"additional-study-needed-for-astrazeneca-vaccine-company","status":"publish","type":"post","link":"https:\/\/buradabiliyorum.com\/en\/additional-study-needed-for-astrazeneca-vaccine-company\/","title":{"rendered":"#’Additional study’ needed for AstraZeneca vaccine: company"},"content":{"rendered":"

“#’Additional study’ needed for AstraZeneca vaccine: company<\/strong>”<\/p>\n

\n
\n
\n
\"vaccine\"
\n Credit: Unsplash\/CC0 Public Domain
\n <\/figcaption><\/figure>\n<\/div>\n<\/div>\n

The head of British drug manufacturer AstraZeneca said on Thursday further research was needed on its COVID-19 vaccine after questions emerged over the protection it could offer.<\/p>\n

“Now that we’ve found what looks like a better efficacy we have to validate this, so we need to do an additional study,” chief executive Pascal Soriot told Bloomberg in an interview.\n <\/p>\n\n

\n

Follow the latest news<\/a> on the coronavirus (COVID-19) outbreak\n <\/p><\/div>\n

\n

\n \u00a9 2020 AFP<\/p>\n

<\/p>\n

\n

Citation<\/strong>:
\n ‘Additional study’ needed for AstraZeneca vaccine: company (2020, November 26)
\n retrieved 26 November 2020
\n from https:\/\/medicalxpress.com\/news\/2020-11-additional-astrazeneca-vaccine-company.html<\/p>\n

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
\n part may be reproduced without the written permission. The content is provided for information purposes only.<\/p><\/div>\n<\/p><\/div>\n